Variability of familial risk of Alzheimer disease across the late life span

Archives of General Psychiatry

Volumn 62, Issue 5, 2005, Pages 565-573

  Silverman, Jeremy M ^a,b   Ciresi, Gregory ^c   Smith, Christopher J ^a,b   Marin, Deborah B ^a   Schnaider Beeri, Michal ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; ENVIRONMENTAL FACTOR; FEMALE; GENETIC RISK; HAZARD ASSESSMENT; HUMAN; INFORMED CONSENT; LIFESPAN; MAJOR CLINICAL STUDY; MALE; NURSING HOME; ONSET AGE; OUTCOMES RESEARCH; PARENT; QUESTIONNAIRE; RELATIVE; RETROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SIBLING; SURVIVAL;

AGE FACTORS; AGE OF ONSET; AGED; ALZHEIMER DISEASE; FAMILY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERVIEWS; MALE; PEDIGREE; PROPORTIONAL HAZARDS MODELS; QUESTIONNAIRES; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 18244409886     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.62.5.565     Document Type: Article

References (47)

1. Hendrie HC. Epidemiology of dementia and Alzheimer's disease. Am J Geriatr Psychiatry. 1998;6:S3-18.
2. Tanzi RE, Bertram L. New frontiers in Alzheimer's disease genetics. Neuron. 2001;32:181-184.
3. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van Duijn CM. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer's disease: a meta-analysis. JAMA. 1997;278:1349-1356.
4. Li G, Silverman JM, Altstiel LD, Haroutunian V, Perl DP, Purohit D, Birstein S, Lantz M, Mohs RC, Davis KL. Apolipoprotein E-epsilon 4 allele and familial risk in Alzheimer's disease. Genet Epidemiol. 1996;13:285-298.
5. Papassotiropoulos A, Streffer JR, Tsolaki M, Schmid S, Thai D, Nicosia F, Iakovidou V, Maddalena A, Lutjohann D, Ghebremedhin E, Hegi T, Pasch T, Traxler M, Bruhl A, Benussi L, Binetti G, Braak H, Nitsch RM, Hock C. Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism. Arch Neurol. 2003;60:29-35.
6. Lautenschlager NT, Cupples LA, Rao VS, Auerbach SA, Becker R, Burke J, Chui H, Duara R, Foley EJ, Glatt SL, Green RC, Jones R, Karlinsky H, Kukull WA, Kurz A, Larson EB, Martelli K, Sadovnick AD, Volicer L, Waring SC, Growdon JH, Farrer LA. Risk of dementia of Alzheimer's disease patients in the MIRAGE study: what is in store for the oldest old? Neurology. 1996;46:641-650.
7. Li G, Silverman JM, Smith CJ, Zaccario ML, Schmeidler J, Mohs RC, Davis KL. Age at onset and familial risk in Alzheimer's disease. Am J Psychiatry. 1995;152:424-430.
8. Silverman JM, Smith CJ, Marin DB, Mohs RC, Propper CB. Familial patterns of risk in very late-onset Alzheimer disease. Arch Gen Psychiatry. 2003;60:190-197.
9. Statement on use of apolipoprotein E testing for Alzheimer disease: American College of Medical Genetics/American Society of Human Genetics Working Group on ApoE and Alzheimer disease. JAMA. 1995;274:1627-1629.
10. Farlow MR. Alzheimer's disease: clinical implications of the apolipoprotein E genotype. Neurology. 1997;48:S30-S34.
11. Relkin WR, Kwon YJ, Tsai J, Gandy S. The National Institute on Aging/ Alzheimer's Association recommendations on the application of apolipoprotein E genotyping to Alzheimer's disease. Ann N Y Acad Sci. 1996;802:149-176.
12. McConnell LM, Koenig BA, Greely HT, Raffin TA. Genetic testing and Alzheimer disease: has the time come? Alzheimer Disease Working Group of the Stanford Program in Genomics, Ethics & Society. Nat Med. 1998;4:757-759.
13. Bennett C, Crawford F, Osborne A, Diaz P, Hoyne J, Lopez R, Roques P, Duara R, Rossor M, Mullan M. Evidence that the APO E locus influences rate of disease progression in late onset familial Alzheimer's disease but is not causative. Am J Med Genet. 1995;60:1-6.
14. Meyer MR, Tschanz JT, Norton MC, Welsh-Bohmer KA, Steffens DC, Wyse BW, Breitner JC. APOE genotype predicts when - not whether - one is predisposed to develop Alzheimer disease [letter]. Nat Genet. 1998;19:321-322.
15. Khachaturian AS, Corcoran CD, Mayer LS, Zandi PP, Breitner JC. Apolipoprotein E epsilon4 count affects age at onset of Alzheimer disease, but not lifetime susceptibility: the Cache County Study. Arch Gen Psychiatry. 2004;61:518-524.
16. McKhann G, Drachman D, Folstein MF, Katzman R, Price D, Stadlen E. Report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944.
17. Silverman JM, Smith CJ, Marin DB, Schmeidler J, Birstein S, Lantz M, Davis KL, Mohs RC. Has familial aggregation in Alzheimer's disease been over-estimated? Int J Geriatr Psychiatry. 2000;15:631-637.
18. Silverman JM, Breitner JC, Mohs RC, Davis KL. Reliability of the family history method in genetic studies of Alzheimer's disease and related dementias. Am J Psychiatry. 1986;143:1279-1282.
19. Silverman JM, Keefe RS, Mohs RC, Davis KL. A study of the reliability of the family history method in genetic studies of Alzheimer disease. Alzheimer Dis Assoc Disord. 1989;3:218-223.
20. Silverman JM, Li G, Schear S, Wang ZX, Sotolongo C, Somary K, Mohs RC. A cross-cultural family history study of primary progressive dementia in relatives of nondemented elderly Chinese, Italians, Jews and Puerto Ricans. Acta Psychiatr Scand. 1992;85:211-217.
21. Silverman JM, Smith CJ, Marin DB, Birstein S, Mare M, Mohs RC, Davis KL. Identifying families with likely genetic protective factors against Alzheimer disease. Am J Hum Genet. 1999;64:832-838.
22. Silverman JM, Li G, Zaccario ML, Smith CJ, Schmeidler J, Mohs RC, Davis KL. Patterns of risk in first-degree relatives of patients with Alzheimer's disease [see comments]. Arch Gen Psychiatry. 1994;51:577-586.
23. Breitner JC, Folstein MF. Familial Alzheimer's disease: a prevalent disorder with specific clinical features. Psychol Med. 1984;14:63-80.
24. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
25. Ellis RJ, Jan K, Kawas C, Koller WC, Lyons KE, Jeste DV, Hansen LA, Thal LJ. Diagnostic validity of the dementia questionnaire for Alzheimer disease. Arch Neurol. 1998;55:360-365.
26. Kawas C, Segal J, Stewart WF, Corrado M, Thal L. A validation study of the Dementia Questionnaire. Arch Neurol. 1994;51:901-906.
27. Li G, Aryan M, Silverman JM, Haroutunian V, Perl DP, Birstein S, Lantz M, Marin DB, Mohs RC, Davis KL. The validity of the family history method for identifying Alzheimer disease. Arch Neurol. 1997;54:634-640.
28. Klein JP, Moeschberger ML. Survival Analysis: Techniques for Censored and Truncated Data. New York, NY: Springer-Verlag; 1997.
29. Heun R, Papassotiropoulos A, Jessen F, Maier W, Breitner JC, A family study of Alzheimer disease and early- and late-onset depression in elderly patients. Arch Gen Psychiatry. 2001;58:190-196.
30. Li G, Silverman JM, Mohs RC. Clinical genetic studies of Alzheimer's disease. Psychiatr Clin North Am. 1991;14:267-286.
31. S-Plus 6 for Windows. Seattle, Wash: Insightful Corp; 2002.
32. Ashford JW, Mortimer JA. Non-familial Alzheimer's disease is mainly due to genetic factors. J Alzheimers Dis. 2002;4:169-177.
33. Pedersen NL, Gatz M, Berg S, Johansson B. How heritable is Alzheimer's disease late in life? findings from Swedish twins. Ann Neurol. 2004;55:180-185.
34. Silverman JM. Comment on news and primary papers: Swedish twins suggest environment trumps genes in late-onset AD [Alzheimer Research Forum Web site]. December 19, 2003. Available at: http://www.alzforum.org/new/detailprint.asp?id= 934. Accessed January 6, 2004.
35. Breitner JC, Silverman JM, Mohs RC, Davis KL. Familial aggregation in Alzheimer's disease: comparison of risk among relatives of early-and late-onset cases, and among male and female relatives in successive generations. Neurology. 1988;38:207-212.
36. Silverman JM, Raiford K, Edland S, Fillenbaum G, Morris JC, Clark CM, Kukull W, Heyman A. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), Part VI, family history assessment: a multicenter study of first-degree relatives of Alzheimer's disease probands and nondemented spouse controls. Neurology. 1994;44:1253-1259.
37. Huff FJ, Auerbach J, Chakravarti A, Boller F. Risk of dementia in relatives of patients with Alzheimer's disease. Neurology. 1988;38:786-790.
38. Farrer LA, O'Sullivan DM, Cupples LA, Growdon JH, Myers RH. Assessment of genetic risk for Alzheimer's disease among first-degree relatives. Ann Neurol. 1989;25:485-493.
39. Scacchi R, De BL, Mantuano E, Donini LM, Vilardo T, Corbo RM. Apolipoprotein E (APOE) allele frequencies in late-onset sporadic Alzheimer's disease (AD), mixed dementia and vascular dementia: lack of association of epsilon 4 allele with AD in Italian octogenarian patients. Neurosci Lett. 1995;201:231-234.
40. Blacker D, Haines JL, Terwedow H, Go RCP, Harrell LE, Perry RT, Bassett SS, Chase GA, Meyers D, Albert MS, Tanzi R. ApoE-4 and age at onset of Alzheimer's disease. Neurology. 1997;48:139-147.
41. Murman DL, Foster HL, Kilgore SP, McDonagh CA, Fink JK. Apolipoprotein E and Alzheimer's disease: strength of association is related to age at onset. Dementia. 1996;7:251-255.
42. Graff-Radford NR, Green RC, Go RC, Hutton ML, Edeki T, Bachman D, Adamson JL, Griffith P, Willis FB, Williams M, Hipps Y, Haines JL, Cupples LA, Farrer LA. Association between apolipoprotein E genotype and Alzheimer disease in African American subjects. Arch Neurol. 2002;59:594-600.
43. Juva K, Verkkoniemi A, Viramo P, Polvikoski T, Kainulainen K, Kontula K, Sulkava R. APOE epsilon4 does not predict mortality, cognitive decline, or dementia in the oldest old. Neurology. 2000;54:412-415.
44. Frisoni GB, Manfredi M, Geroldi C, Binetti G, Zanetti O, Bianchetti A, Trabucchi M. The prevalence of apoE-epsilon4 in Alzheimer's disease is age dependent. J Neurol Neurosurg Psychiatry. 1998;65:103-106.
45. Sobel E, Louhija J, Sulkava R, Davanipour Z, Kontula K, Miettinen H, Tikkanen M, Kainulainen K, Tilvis R. Lack of association of apolipoprotein E allele epsilon 4 with late-onset Alzheimer's disease among Finnish centenarians. Neurology. 1995;45:903-907.
46. Asada T, Yamagata Z, Kinoshita T, Kinoshita A, Kariya T, Asaka A, Kakuma T. Prevalence of dementia and distribution of ApoE alleles in Japanese centenarians: an almost-complete survey in Yamanashi Prefecture, Japan. J Am Geriatr Soc. 1996;44:151-155.
47. Skoog I, Hesse C, Fredman P, Andreasson LA, Palmertz B, Blennow K. Apolipoprotein E in cerebrospinal fluid in 85-year-old subjects: relation to dementia, apolipoprotein E polymorphism, cerebral atrophy, and white matter lesions. Arch Neurol. 1997;54:267-272.